Aminocandin

DB05128ExperimentalSmall molecule

Aminocandin is a new representative of the echinocandins that could potentially affect the cellular morphology and metabolic status of Candida albicans cells within biofilms.

Primary indication: Investigated for use/treatment in fungal infections.Curator reviewed
Formula / weight: C₅₆H₇₉N₉O₁₄ · 1102.297 g/mol (avg)
Code names: HMR-3270 · IP-960 · NXL-201

Resolves to

Compound

CAS227472-48-2ChEBI84073PubChem16072305

Structure

InChIKeyUMNFJRNUJIBDSK-NMVZEWDOSA-NSMILES

CCCCCCCCOC1=CC=C(C=C1)C1=CC=C(C=C1)C(=O)N[C@H]1CC(CNC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)CC1=CC=C(O)C=C1)NCCN

What you can answer from here — as of March 06, 2025

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Aminocandin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account